Propranolol Extended-Release Capsules Recall: Lot Number, Metal Contamination Risk and What to Do

Propranolol 60 mg extended-release capsules recalled nationwide over possible metal contamination. Check the affected lot number, expiration date and safety instructions.

Published on by

Propranolol Extended-Release Capsules Recall: Lot Number, Metal Contamination Risk and What to Do

Propranolol extended-release capsules have been recalled nationwide in the United States after the manufacturer warned that one batch of the blood pressure medication could contain metal contamination.

Breckenridge Pharmaceutical, Inc. announced the voluntary recall on November 16, 2026, covering one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg.

The company warned that taking capsules from the affected batch could cause cuts or injuries to soft tissues in the mouth, esophagus, stomach or intestines.

The recalled medication was distributed to wholesalers and pharmacies across the United States between October 26 and November 4, 2026.

Patients and pharmacies are being urged to check the product's lot number and expiration date to determine whether their medication is affected.

Here is what patients need to know about the propranolol recall, including the affected batch, potential health risks and what to do if they have the recalled capsules.

Which Propranolol Medication Has Been Recalled?

The recall affects one specific lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions and distributed by Breckenridge Pharmaceutical.

The affected medication comes in bottles containing 100 capsules.

Patients can use the following information to identify the recalled product:

Product informationRecall details
MedicationPropranolol Hydrochloride Extended-Release Capsules, USP
Strength60 mg
ManufacturerAdare Pharma Solutions
DistributorBreckenridge Pharmaceutical, Inc.
Package size100-count bottle
NDC number51991-817-01
Recalled lot numberPK25110035
Expiration dateMay 2029
Distribution periodOctober 26–November 4, 2026

The affected lot number is PK25110035.

The recall does not cover every propranolol product or every strength of the medication. It specifically identifies the 60 mg extended-release capsules from the lot listed above.

Patients should check the information printed on their medication bottle rather than assuming that every propranolol prescription is affected.

Why Were Propranolol Extended-Release Capsules Recalled?

Breckenridge Pharmaceutical recalled the affected batch because of the possibility of metal contamination.

According to the company's recall announcement, the affected lot shared intermediate manufacturing material suspected to be the source of metal contamination identified in a separate lot.

That other lot was not released to the market.

The company warned that capsules from the recalled batch could contain metal fragments that may cause physical injuries if swallowed.

The recall is being conducted with the knowledge of the US Food and Drug Administration (FDA).

Breckenridge said it was not aware of any adverse events assessed to be related to the recall when it announced the action.

What Are the Health Risks of Taking the Recalled Propranolol?

The main concern is that metal fragments in the capsules could cause lacerations, meaning cuts or tears, to soft tissues in the body.

The manufacturer specifically identified possible injuries involving:

  • Oral cavity: Soft tissues inside the mouth.
  • Esophagus: The passage connecting the mouth to the stomach.
  • Stomach: The organ responsible for processing swallowed food and medication.
  • Intestines: Parts of the digestive system responsible for digestion and absorption.

The severity of a potential injury would depend on the nature and amount of contamination and the circumstances of exposure.

The company had not reported any adverse events assessed as related to the recall at the time of its announcement.

Patients who have taken capsules from the affected batch and experience unusual symptoms should contact a healthcare professional promptly.

Anyone experiencing severe symptoms or a medical emergency should seek urgent medical attention.

What Should You Do If You Have the Recalled Propranolol Capsules?

Breckenridge Pharmaceutical has advised consumers with the affected lot to stop taking the recalled product and contact their physician or healthcare provider for medical advice and replacement instructions.

The company also says unused capsules should be returned to the pharmacy where they were obtained.

If you have propranolol capsules, take these steps:

  1. Check the lot number: Look for PK25110035 on the medication bottle.
  2. Check the strength: The recall concerns 60 mg extended-release capsules.
  3. Check the expiration date: The affected bottles carry an expiration date of May 2029.
  4. Contact your healthcare provider: Ask for instructions on replacing the affected medication.
  5. Contact your pharmacy: Arrange to return any unused capsules from the recalled batch.
  6. Report possible health problems: Contact a healthcare professional if you believe you experienced an adverse reaction.

Do not assume that all propranolol products have been recalled.

Propranolol is a prescription medication, and suddenly interrupting beta-blocker treatment can carry health risks. Contact your prescriber or pharmacist promptly for instructions on maintaining your treatment safely while replacing an affected product. Do not independently substitute another medication or change your prescribed dose.

Why Is Propranolol Used?

Propranolol is a beta-blocker prescribed for several cardiovascular and other medical conditions.

Depending on the formulation and prescription, it may be used to treat:

  • High blood pressure.
  • Certain heart rhythm problems.
  • Angina, or chest pain associated with heart disease.
  • Migraine prevention.
  • Other conditions for which a healthcare professional considers it appropriate.

Extended-release capsules are designed to release medication over a longer period than immediate-release formulations.

The current recall concerns the specific 60 mg extended-release capsule lot identified by Breckenridge Pharmaceutical.

It is not an announcement that propranolol as a medication has been withdrawn from the market.

When Were the Recalled Propranolol Capsules Distributed?

According to Breckenridge Pharmaceutical, the affected lot was distributed nationwide to wholesalers and pharmacies between October 26 and November 4, 2026.

The recall was announced on November 16, 2026.

The distribution information matters because patients may have received the affected bottles through different pharmacies and healthcare providers across the United States.

Pharmacies, wholesalers and other retailers have been instructed to check their inventories, quarantine the affected products and stop distributing or dispensing them.

Businesses that supplied the medication to other retailers have also been asked to notify those recipients.

How Can You Contact Breckenridge About the Recall?

Breckenridge has appointed Qualanex as its recall service provider for consumer questions and concerns.

Patients can contact the recall service using the following details:

Contact informationDetails
Telephone1-855-736-0807
Emailrecall@qualanex.com
Operating daysMonday to Friday
Operating hours9 a.m. to 5 p.m. Eastern Time

Patients who experience adverse reactions or identify product quality problems can also report them through the FDA's MedWatch programme.

Official reporting website: https://www.fda.gov/medwatch/report.htm

Is the Propranolol Recall Nationwide?

Yes. Breckenridge announced a voluntary nationwide consumer-level recall covering the affected lot distributed to wholesalers and pharmacies across the United States.

However, nationwide distribution does not mean that every propranolol bottle in the country is affected.

The recall identifies one particular lot of 60 mg extended-release capsules.

Patients should verify the lot number, NDC and expiration date on their medication packaging before deciding whether their product is included.

The announcement does not establish that the recalled batch was distributed internationally.

Frequently Asked Questions About the Propranolol Recall

Which propranolol has been recalled?

Breckenridge Pharmaceutical recalled one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions.

What is the recalled propranolol lot number?

The affected lot number is PK25110035.

What is the expiration date of the recalled propranolol?

The recalled 100-count bottles have an expiration date of May 2029.

Why was propranolol recalled in November 2026?

The medication was recalled because of potential metal contamination that could cause cuts or lacerations to soft tissues in the mouth, esophagus, stomach or intestines.

Is all propranolol recalled?

No. The announcement covers one specific lot of 60 mg extended-release capsules. It does not establish a recall of every propranolol strength, formulation or manufacturer.

Who manufactured the recalled propranolol?

Adare Pharma Solutions manufactured the capsules, while Breckenridge Pharmaceutical distributed the affected product.

Has anyone been injured by the recalled propranolol?

Breckenridge said it was not aware of any adverse events assessed as related to the recall when the announcement was issued.

What should I do if I have lot PK25110035?

The manufacturer advises consumers to stop taking the affected lot, contact their healthcare provider for medical advice and replacement instructions, and return unused capsules to the pharmacy where they were purchased.

Can I continue taking another brand of propranolol?

The recall does not cover every propranolol product. However, patients should confirm their specific medication with their pharmacist or prescriber and should not independently change or interrupt their prescribed treatment.

How do I report a reaction to the recalled medication?

Contact your healthcare provider and report suspected adverse reactions or product quality problems through the FDA's MedWatch programme at https://www.fda.gov/medwatch/report.htm.

Final Takeaway

The November 2026 propranolol recall affects one lot of 60 mg extended-release capsules distributed by Breckenridge Pharmaceutical across the United States.

The affected product carries lot number PK25110035, NDC 51991-817-01 and an expiration date of May 2029.

The company recalled the batch over possible metal contamination that could cause injuries to soft tissues in the mouth and digestive tract.

Patients should check their medication packaging, contact their healthcare providers for replacement instructions if they have the affected lot, and return unused capsules to their pharmacy.

The recall does not mean that every propranolol prescription or every blood pressure medication has been withdrawn.

Sources and Further Reading

Related Articles

Video Editorial Context: Watch and review key insights and reporting regarding Blood Pressure Pill Recall (Oct 2026): Should Seniors Worry? How to Check Your Bottle. This verified video provides essential context and primary source footage supporting our coverage.

Videos in this article

Watch editorial video coverage: Propranolol Extended-Release Capsules Recall: Lot Number, Metal Contamination Risk and What to Do

More on this Story & Related In-Depth Reports

technology

United Airlines Outage: Why Flights Were Delayed, What Happened and Latest Update

United Airlines Outage: Why Flights Were Delayed, What Happened and Latest Update United Airlines experienced a widespre...

technology

Is the NSA Down? What Happened to NSA Net and Its Classified Communications Network?

Is the NSA Down? What Happened to NSA Net and Its Classified Communications Network? Is the US National Security Agency ...

technology

How Were 178 Websites Hacked? Who Was Behind the Optimizely Cyberattack and When Did It Happen?

How Were 178 Websites Hacked? Who Was Behind the Optimizely Cyberattack and When Did It Happen? A cyberattack involving ...

technology

Cyberattack Hits 178 Organisations: CNN, BBC and Zoom Visitors Targeted by Malware

Cyberattack Hits 178 Organisations: CNN, BBC and Zoom Visitors Targeted by Malware A major cybersecurity incident has af...